MedPath

HYPERTET

HYPERTET

Approved
DIN Number

02520087

Drug Class

Human

Market Date

Dec 13, 2021

Company
HC

基立福

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02520087
AIG Number0133051001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J06BB02 TETANUS IMMUNOGLOBULIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification80:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TETANUS IMMUNOGLOBULIN (HUMAN)Active
Strength: 250 UNIT / ML
Monograph: TETANUS IMMUNOGLOBULIN (HUMAN)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.